GM23630
LCL from B-Lymphocyte
Description:
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5
FUKUTIN-RELATED PROTEIN; FKRP
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Muscular Dystrophies CMD Specific |
Class |
Congenital Muscle Diseases |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
LCL from B-Lymphocyte
|
Race
|
White
|
Ethnicity
|
Not Hispanic/Latino
|
Family Member
|
1
|
Family History
|
N
|
Relation to Proband
|
proband
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
|
Gene |
FKRP |
Chromosomal Location |
19q13.3 |
Allelic Variant 1 |
; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5 |
Identified Mutation |
826C>A |
|
Gene |
FKRP |
Chromosomal Location |
19q13.3 |
Allelic Variant 1 |
; |
Identified Mutation |
c.135C>T; silent mutation |
|
Gene |
FKRP |
Chromosomal Location |
19q13.3 |
Allelic Variant 2 |
; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5 |
Identified Mutation |
826C>A |
|
Gene |
FKRP |
Chromosomal Location |
19q13.3 |
Allelic Variant 2 |
; |
Identified Mutation |
c.135C>T; silent mutation |
Remarks |
Symptom onset at age range 11-15 years; cardiac involvement; brain involvement; motor functions achieved and currently maintained: hold head up without assistance, sit without assistance, walk indoors without assistance; motor function achieved but not currently maintained: turn in bed without assistance, stand without assistance, walk outdoors without assistance, climb stairs with a handrail, and run with feet leaving the ground; Fukutin related protein gene (FKRP) sequence analysis result: homozygous for c.826C>A (leucine to isoleucine) DNA variation in exon 4; subject is also homozygous for one known polymorphism: c.135C>T (alanine to alanine) in exon 4 resulting in a silent mutation; MRI or CT scan findings: cerebellar tonsils ( 6 mm below foramen magnum); borderline Chiari 1 malformation; respiratory support used greater than 12 hours a day; see GM23868 for fibroblast. |
Split Ratio |
1:4 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
AMBIENT |
Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not Inactivated |
Supplement |
- |
|
|